Global and China Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2026

Publisher Name :
Date: 18-Sep-2020
No. of pages: 142
Inquire Before Buying

Nuclear Medicine & Radiopharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine & Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Nuclear Medicine & Radiopharmaceuticals market is segmented into

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Segment by Application, the Nuclear Medicine & Radiopharmaceuticals market is segmented into

- Oncology

- Cardiology

- Other

Regional and Country-level Analysis

The Nuclear Medicine & Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).

The key regions covered in the Nuclear Medicine & Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Nuclear Medicine & Radiopharmaceuticals Market Share Analysis

Nuclear Medicine & Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine & Radiopharmaceuticals business, the date to enter into the Nuclear Medicine & Radiopharmaceuticals market, Nuclear Medicine & Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

Global and China Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Nuclear Medicine & Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic Radioisotopes
1.4.3 Therapeutic Radioisotopes
1.5 Market by Application
1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2015-2026
2.2 Global Nuclear Medicine & Radiopharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Nuclear Medicine & Radiopharmaceuticals Historical Market Size by Region (2015-2020)
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2021-2026)
2.4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
3 Global Nuclear Medicine & Radiopharmaceuticals Competitor Landscape by Players
3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Medicine & Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine & Radiopharmaceuticals Revenue in 2019
3.2.5 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturers
3.4 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2015-2020)
4.1.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2015-2020)
5.1.3 Nuclear Medicine & Radiopharmaceuticals Price by Application (2015-2020)
5.2 Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
6.1.1 China Nuclear Medicine & Radiopharmaceuticals Sales YoY Growth 2015-2026
6.1.2 China Nuclear Medicine & Radiopharmaceuticals Revenue YoY Growth 2015-2026
6.1.3 China Nuclear Medicine & Radiopharmaceuticals Market Share in Global Market 2015-2026
6.2 China Nuclear Medicine & Radiopharmaceuticals Market Size by Players (International and Local Players)
6.2.1 China Top Nuclear Medicine & Radiopharmaceuticals Players by Sales (2015-2020)
6.2.2 China Top Nuclear Medicine & Radiopharmaceuticals Players by Revenue (2015-2020)
6.3 China Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Type (2015-2020)
6.3.1 China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2015-2020)
6.3.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
6.3.3 China Nuclear Medicine & Radiopharmaceuticals Price by Type (2015-2020)
6.4 China Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2021-2026)
6.4.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
6.4.3 China Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type (2021-2026)
6.5 China Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Application (2015-2020)
6.5.1 China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020)
6.5.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
6.5.3 China Nuclear Medicine & Radiopharmaceuticals Price by Application (2015-2020)
6.6 China Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2021-2026)
6.6.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
6.6.3 China Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2021-2026)
7 North America
7.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
7.2 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020)
7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
8.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
8.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
9.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2015-2020)
9.2.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
10.2 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country
10.2.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
11.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Description and Business Overview
12.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Description and Business Overview
12.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Nuclear Medicine & Radiopharmaceuticals Products Offered
12.2.5 Bayer Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Description and Business Overview
12.3.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Nordion
12.4.1 Nordion Corporation Information
12.4.2 Nordion Description and Business Overview
12.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Nordion Nuclear Medicine & Radiopharmaceuticals Products Offered
12.4.5 Nordion Recent Development
12.5 Triad Isotopes
12.5.1 Triad Isotopes Corporation Information
12.5.2 Triad Isotopes Description and Business Overview
12.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Products Offered
12.5.5 Triad Isotopes Recent Development
12.6 Lantheus
12.6.1 Lantheus Corporation Information
12.6.2 Lantheus Description and Business Overview
12.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Products Offered
12.6.5 Lantheus Recent Development
12.7 IBA Group
12.7.1 IBA Group Corporation Information
12.7.2 IBA Group Description and Business Overview
12.7.3 IBA Group Sales, Revenue and Gross Margin (2015-2020)
12.7.4 IBA Group Nuclear Medicine & Radiopharmaceuticals Products Offered
12.7.5 IBA Group Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Corporation Information
12.8.2 GE Healthcare Description and Business Overview
12.8.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Products Offered
12.8.5 GE Healthcare Recent Development
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Corporation Information
12.9.2 China Isotope & Radiation Description and Business Overview
12.9.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
12.9.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
12.9.5 China Isotope & Radiation Recent Development
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Corporation Information
12.10.2 Jubilant Pharma Description and Business Overview
12.10.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
12.10.5 Jubilant Pharma Recent Development
12.11 Bracco Imaging
12.11.1 Bracco Imaging Corporation Information
12.11.2 Bracco Imaging Description and Business Overview
12.11.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
12.11.5 Bracco Imaging Recent Development
12.12 Advanced Accelerator Applications
12.12.1 Advanced Accelerator Applications Corporation Information
12.12.2 Advanced Accelerator Applications Description and Business Overview
12.12.3 Advanced Accelerator Applications Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Advanced Accelerator Applications Products Offered
12.12.5 Advanced Accelerator Applications Recent Development
12.13 SIEMENS
12.13.1 SIEMENS Corporation Information
12.13.2 SIEMENS Description and Business Overview
12.13.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
12.13.4 SIEMENS Products Offered
12.13.5 SIEMENS Recent Development
12.14 Dongcheng
12.14.1 Dongcheng Corporation Information
12.14.2 Dongcheng Description and Business Overview
12.14.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Dongcheng Products Offered
12.14.5 Dongcheng Recent Development
12.15 Navidea
12.15.1 Navidea Corporation Information
12.15.2 Navidea Description and Business Overview
12.15.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Navidea Products Offered
12.15.5 Navidea Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Medicine & Radiopharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Medicine & Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Nuclear Medicine & Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diagnostic Radioisotopes
Table 5. Major Manufacturers of Therapeutic Radioisotopes
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2019)
Table 16. Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2015-2020) (USD/Unit)
Table 19. Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 21. Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 24. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 27. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Companies (2015-2020)
Table 36. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Company (2015-2020)
Table 37. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 38. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 39. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 40. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Nuclear Medicine & Radiopharmaceuticals Price (K Units) by Type (2015-2020)
Table 42. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2021-2026)
Table 43. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 44. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2026)
Table 46. China Nuclear Medicine & Radiopharmaceuticals Price (K Units) by Type (2021-2026)
Table 47. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 48. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 49. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2021-2026)
Table 51. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 52. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2026)
Table 54. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 55. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 56. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 58. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 59. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 60. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 66. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 67. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 74. Bracco Imaging Corporation Information
Table 75. Bracco Imaging Description and Business Overview
Table 76. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product
Table 78. Bracco Imaging Recent Development
Table 79. Bayer Corporation Information
Table 80. Bayer Description and Business Overview
Table 81. Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Bayer Product
Table 83. Bayer Recent Development
Table 84. Mallinckrodt Corporation Information
Table 85. Mallinckrodt Description and Business Overview
Table 86. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Mallinckrodt Product
Table 88. Mallinckrodt Recent Development
Table 89. Nordion Corporation Information
Table 90. Nordion Description and Business Overview
Table 91. Nordion Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Nordion Product
Table 93. Nordion Recent Development
Table 94. Triad Isotopes Corporation Information
Table 95. Triad Isotopes Description and Business Overview
Table 96. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Triad Isotopes Product
Table 98. Triad Isotopes Recent Development
Table 99. Lantheus Corporation Information
Table 100. Lantheus Description and Business Overview
Table 101. Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Lantheus Product
Table 103. Lantheus Recent Development
Table 104. IBA Group Corporation Information
Table 105. IBA Group Description and Business Overview
Table 106. IBA Group Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. IBA Group Product
Table 108. IBA Group Recent Development
Table 109. GE Healthcare Corporation Information
Table 110. GE Healthcare Description and Business Overview
Table 111. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. GE Healthcare Product
Table 113. GE Healthcare Recent Development
Table 114. China Isotope & Radiation Corporation Information
Table 115. China Isotope & Radiation Description and Business Overview
Table 116. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. China Isotope & Radiation Product
Table 118. China Isotope & Radiation Recent Development
Table 119. Jubilant Pharma Corporation Information
Table 120. Jubilant Pharma Description and Business Overview
Table 121. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Jubilant Pharma Product
Table 123. Jubilant Pharma Recent Development
Table 124. Eli Lilly Corporation Information
Table 125. Eli Lilly Description and Business Overview
Table 126. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Eli Lilly Product
Table 128. Eli Lilly Recent Development
Table 129. Advanced Accelerator Applications Corporation Information
Table 130. Advanced Accelerator Applications Description and Business Overview
Table 131. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Advanced Accelerator Applications Product
Table 133. Advanced Accelerator Applications Recent Development
Table 134. SIEMENS Corporation Information
Table 135. SIEMENS Description and Business Overview
Table 136. SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. SIEMENS Product
Table 138. SIEMENS Recent Development
Table 139. Dongcheng Corporation Information
Table 140. Dongcheng Description and Business Overview
Table 141. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Dongcheng Product
Table 143. Dongcheng Recent Development
Table 144. Navidea Corporation Information
Table 145. Navidea Description and Business Overview
Table 146. Navidea Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Navidea Product
Table 148. Navidea Recent Development
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Nuclear Medicine & Radiopharmaceuticals Players
Table 153. Nuclear Medicine & Radiopharmaceuticals Customers List
Table 154. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Radioisotopes Product Picture
Figure 4. Therapeutic Radioisotopes Product Picture
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales 2015-2026 (K Units)
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2019
Figure 19. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type in 2019
Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2019
Figure 29. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2026 (K Units)
Figure 30. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Nuclear Medicine & Radiopharmaceuticals Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in Nuclear Medicine & Radiopharmaceuticals in 2019
Figure 33. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2015-2020)
Figure 34. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2015-2020)
Figure 36. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 40. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 41. U.S. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 48. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 49. Germany Nuclear Medicine & Radiopharmaceuticals Sales Growt
  • X-linked adrenoleukodystrophy (X-ALD) - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "X-linked adrenoleukodystrophy (X-ALD) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the X-linked adrenoleukodystrophy (X-ALD) , historical and forecasted epidemiology as well as the X-linked adrenoleukodystrophy (X-ALD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The X-linked adrenoleukodystrophy (X-ALD) market report provides current treatment practices, ......
  • Vestibular Schwannoma (VS) - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Vestibular Schwannoma (VS) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Vestibular Schwannoma (VS) , historical and forecasted epidemiology as well as the Vestibular Schwannoma (VS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Vestibular Schwannoma (VS) market report provides current treatment practices, emerging drugs, Vestibular Schwannoma (VS) ......
  • Vertigo - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Vertigo - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Vertigo , historical and forecasted epidemiology as well as the Vertigo market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Vertigo market report provides current treatment practices, emerging drugs, Vertigo market share of the individual therapies, current and forecasted Vertigo market Size from 2017......
  • Ventricular Tachycardia (V-tach or VT) - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Ventricular Tachycardia (V-tach or VT) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Ventricular Tachycardia (V-tach or VT) , historical and forecasted epidemiology as well as the Ventricular Tachycardia (V-tach or VT) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ventricular Tachycardia (V-tach or VT) market report provides current treatment practic......
  • Uterine Fibroids & Endometriosis - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Uterine Fibroids & Endometriosis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Uterine Fibroids & Endometriosis , historical and forecasted epidemiology as well as the Uterine Fibroids & Endometriosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Uterine Fibroids & Endometriosis market report provides current treatment practices, emerging drugs, Uter......
  • Unresectable Melanoma - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Unresectable Melanoma - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Unresectable Melanoma , historical and forecasted epidemiology as well as the Unresectable Melanoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Unresectable Melanoma market report provides current treatment practices, emerging drugs, Unresectable Melanoma market share of the indiv......
  • Undifferentiated Pleomorphic Sarcoma (UPS) - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Undifferentiated Pleomorphic Sarcoma (UPS) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Undifferentiated Pleomorphic Sarcoma (UPS) , historical and forecasted epidemiology as well as the Undifferentiated Pleomorphic Sarcoma (UPS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Undifferentiated Pleomorphic Sarcoma (UPS) market report provides current t......
  • Trichomoniasis - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Trichomoniasis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Trichomoniasis , historical and forecasted epidemiology as well as the Trichomoniasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Trichomoniasis market report provides current treatment practices, emerging drugs, Trichomoniasis market share of the individual therapies, current and foreca......
  • Topical Skin Infection Treatment - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 20-Oct-2020        Price: US 6950 Onwards        Pages: 200
    DelveInsight's "Topical Skin Infection Treatment - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Topical Skin Infection Treatment , historical and forecasted epidemiology as well as the Topical Skin Infection Treatment market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Topical Skin Infection Treatment market report provides current treatment practices, emerging drugs, Topi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs